Michael C. James - 25 Feb 2026 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Reporting relationship: Director
Issuer ticker: GTHP
Reported as of: 25 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Mar 2026, 15:44:48 UTC
Prior SEC filing: 05 Sep 2025
Next SEC filing: 07 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael C James

Key filing fact

Michael C. James filed Form 4 for GUIDED THERAPEUTICS INC (GTHP) on 04 Mar 2026.

Key facts

This page summarizes Michael C. James's Form 4 filing for GUIDED THERAPEUTICS INC (GTHP).
6 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 04 Mar 2026, 15:44.

Change

Previous filing in this sequence was filed on 05 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001365831 Primary reporting owner

JAMES MICHAEL C

Relationship: Director
Address: 5835 PEACHTREE CORNERS EAST, SUITE B, PEACHTREE CORNERS
Signature: /s/ Michael C James
Signature date: 04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GTHP transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: +100,000
Change %: +18%
Price
Shares after: 653,495
Date: 25 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GTHP transaction Derivative

Warrants

Other

Transaction value
Shares: -100,000
Change %: -100%
Price
Shares after: 0
Date: 25 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.5000
Footnotes: F1

GTHP transaction Derivative

Warrants

Other

Transaction value
Shares: +100,000
Change %
Price
Shares after: 100,000
Date: 25 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.5000
Footnotes: F1

GTHP transaction Derivative

Warrants

Other

Transaction value
Shares: -100,000
Change %: -100%
Price
Shares after: 0
Date: 25 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.6500
Footnotes: F1

GTHP transaction Derivative

Warrants

Other

Transaction value
Shares: +100,000
Change %: +189%
Price
Shares after: 152,778
Date: 25 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.2500
Footnotes: F1

GTHP transaction Derivative

Warrants

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: -100,000
Change %: -65%
Price
Shares after: 52,778
Date: 25 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.2500
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

During February 2026, Mr. James signed an exchange agreement to exchange 100,000 warrants to purchase shares of common stock with an exercise price of $0.65 for 100,000 warrants to purchase shares of common stock for an exercise price of $0.25. The newly exchanged warrants were subsequently exercised upon payment of $25,000. Moreover, as part of the exchange agreement, the expiration date of 4-year 100,000 warrants to purchase shares of common stock with exercise price of $0.50 was extended for an additional year, until September 1, 2027.